RBC Has 5 Biotech Stocks Rated Outperform With Up to 100% Upside Potential
These five top biotech companies range from a large-cap leader with a potential coronavirus treatment to a small-cap company with massive upside potential.
These five top biotech companies range from a large-cap leader with a potential coronavirus treatment to a small-cap company with massive upside potential.
The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks shrank.
Tuesday's top analyst upgrades and downgrades included BHP, Electronic Arts, Gilead Sciences, Immunomedics, KeyCorp, Peloton Interactive, Shopify, Sunnova Energy, Take-Two Interactive and Walt Disney.
These five top companies have large troves of cash and very little debt. Their stocks make sense for long-term growth investors who have an eye on recovery down the road.
Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news, though, was lurking in Nevada federal district court.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
U.S. consumer confidence continues to decline, but the slide has slowed. On Sunday, the FDA and the Department of Health and Human Services okayed two drugs for use in the fight against…
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Wednesday's top analyst calls included Apple, CenturyLink, Charles Schwab, Coca-Cola, Dow, Facebook, Gilead Sciences, Intel, Medtronic, Square, TJX and Under Armour.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
24/7 Wall St. has tracked multiple S&P 500 and other large-cap stocks that actually closed up for the past week and that are also still higher year to date.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this novel coronavirus. Here's how they fared as the week wound…
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Markets looked like they would be crushed yet again on Monday. 24/7 Wall St. has tracked some stocks that either are defensive in general or were defying Monday’s big drop.
24/7 Wall St. has tracked some stocks that either are defensive in general or are defying Thursday’s big drop because they have some aspect of their business that might be immune to…